We have a treatment in COVID-19 and it doesn’t have the support of Big Pharma and their experts!
Hydroxychloroquine (HCQ) is effective in treating COVID-19.
It is effective in halting the progression of the disease, provided it is given early enough and provided it is given in accordance with “contraindications” and safety of use (cardiac).
It costs nothing and the powerful pharmaceutical industry does not want to hear about it.
Big Parma has done everything to outlaw and demonize it, including the publication in the most prestigious medical journal (Lancet) of a fraudulent article withdrawn 12 days later.
Let’s stop saying that there is no treatment for COVID-19 or that only a vaccine will save us!
There is a treatment for this disease, not in intensive care, where it is too late, but to prevent it from going to intensive care, so to be given early enough, by general practitioners or emergency doctors.
The key to defeat COVID-19 already exists. We need to start using it
Harvey Risch, MD, PhD, is Professor of Epidemiology at the renowned Yale University School of Public Health.
“As Professor of Epidemiology at the Yale School of Public Health, I have authored more than 300 peer-reviewed publications and currently hold leadership positions on the editorial boards of several leading journals. I’m used to advocating positions within the medical establishment, so I was disconcerted to find that in the midst of a crisis, I had to fight for a treatment that was fully supported by the data, but for reasons unrelated to a proper understanding of the science, was sidelined. As a result, tens of thousands of COVID-19 patients are dying needlessly. Fortunately, the situation can be reversed easily and quickly.
I’m talking, of course, about the drug hydroxychloroquine.”
Effectiveness of hydroxychloroquine confirmed in the University of Minnesota (Boulware) clinical trial data study
These results show that the time elapsed between infection and the start of treatment is crucial for the effectiveness of hydroxychloroquine as a treatment for Covid-19 .
“There is strong statistical evidence that treatment with hydroxychloroquine reduces the proportion of symptomatic patients when used prophylactically immediately after exposure, especially if treatment is started within 2 days. “
Hydroxychloroquine (HCQ)  has been prescribed in malaria (malaria) and autoimmune diseases (lupus erythematosus, rheumatoid arthritis)  for a very long time.
The antiviral efficacy of HCQ has been demonstrated in vitro for a long time, but also in the case of SARS-CoV-2 (COVID-19) .
Azithromycin, an antibiotic associated with HCQ in the Marseille protocol developed by Professor D Raoult’s team  is also antiviral.
Studies confirm the antiviral role of zinc [5-6] and its ability to inhibit a virus such as SARS-CoV-2 .
Thus, HCQ, azithromycin and zinc are three antivirals. They support each other: studies have shown that zinc facilitates intracellular penetration of HCQ and increases its antiviral action .
HCQ is an inexpensive drug.
Its side effects are known to doctors; they are easy to control.
The antiviral efficacy of HCQ is based on solid experimental data, the experience of a team of experts in these fields (infectiology, virology) and on convincing clinical results : reduction of the contagious period, reduction of the duration of symptoms, blocking the evolution towards a severe form.
These benefits have been verified by French doctors [10-11-12] and by doctors from other countries, Morocco, Algeria, South Korea and China [13-14-15].
Cardiac safety is easy to optimize, especially under medical supervision .
By showing only the studies or scientific opinions on hydroxychloroquine, focusing on its ineffectiveness and/or its dangers, without mentioning the exculpatory studies and opinions that prove its effectiveness, the biased media have sowed a biased, misleading vision in the public mind.
When the incriminating studies in question proved to be false or falsified, such as this study published in The Lancet on May 22, 2020 , a scandal forcing the journal to retract the study on June 4, 2020, the media did not mention it!
When studies confirm the effectiveness of hydroxychloroquine (HCQ) in COVID-19 , the media do not report on it!
“The body of evidence now makes a strong case for the effectiveness of this treatment (HCQ), but doctors and the public are convinced otherwise as a result of this selection.” 
Conversely, despite their real danger and ineffectiveness, antivirals (Remdesivir) are praised by these media!
So what action should be taken:
- Facilitate HCQ treatment which is currently being blocked in favor of Big Pharma antivirals (such as Remdesivir-Gilead). The latter are much more profitable for the pharmaceutical industry than HCQ?
- To negate the value of an urgent (and also very profitable for the same pharmaceutical industry) vaccine?
In the wake of such hypotheses, some naïve or complicit journalists will cry conspiracy. Yet it is documented, proven!
The corruption of science and medicine by the industry concerned has been developed, documented, demonstrated and explained for many years.
Authors, researchers and whistleblowers have proven these malpractices.
Among them are journalists, doctors, professors, university deans, lecturers at universities and colleges, members of parliament, pharmacists, veterinarians, repentant CEOs of pharmaceutical companies, international experts and repentant editors of major scientific journals [20 to 32].
What more is needed?
The pharmaceutical industry, the most powerful lobby of all [33-34], has infiltrated and infiltrated all official decision-making bodies in most countries.
This pandemic corruption has ramifications at all levels of society [35-36-37] including, even more importantly, within governments and public institutions  which have a mandate to protect people’s health.
No one is spared.
Billions (dollars, euros) are at stake .
1000 billion euros of profit in 20 years! No ethics is big enough to fight against that, in a world like ours.
Do you think this overpowering industry would overlook the profits generated by antivirals (formerly Roche’s Tamiflu°, now Gilead’s Remdesivir) or vaccines?
And miss out on a treatment that no longer makes them any money: HCQ?
As soon as the crisis began, Belgium set up a “COVID-19 scientific committee”.
This committee is not transparent! At most, we know a few personalities on this committee, some of whom were already manoeuvring in 2009 to get the government to buy millions of doses of H1N1 vaccine, this time for the benefit of GSK (Glaxo SmithKline).
In 2020, in the COVID-19 crisis, we find the same people, the same scenarios:
Promote testing [40-41], antivirals that are expensive for companies, and above all, vaccination, as in 2009:
“Invited on a Radio 1 programme, virologist Marc van Ranst (one of the heads of the COVID-19 safety committee in Belgium) recalled that the development of a vaccine was the only way to get rid of the new coronavirus in the long term.” .
While the pharmaceutical companies and their lobbies must be very pleased with this statement, and while no journalist in the mainstream media questions this kind of assertion, the public deserves information that is closer to the truth.
No, the development of a vaccine is not the only way to get rid of the new coronavirus in the long term!
Hydroxychloroquine (HCQ) is cheaper, less dangerous and we already have it!
Dr Pascal Sacré
Translation from French by Maya on behalf of GlobalResearch.ca
Featured image: pixnio.com
COVID-19: au plus près de la vérité. Confinement
COVID-19: au plus près de la vérité. Masques
COVID-19: au plus près de la vérité – Tests et Immunité
COVID-19: au plus près de la vérité. Vaccins.
Note to readers: please click on the share buttons above or below. Forward this article to your mailing lists. Publish this article on your blog site, web forums, etc.
 PLAQUENIL 200 mg, comprimé pelliculé Sulfate d’hydroxychloroquine
 The prescribing of chloroquine and hydroxychloroquine by consultant rheumatologists in the UK, Br J Rheumatol. 26 octobre 1987
 In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Clin Infect Dis 9 mars 2020. Hydroxychloroquine was found to be more potent than chloroquine to inhibit SARS-CoV-2 in vitro.
 Coronavirus : Protocole, risques, 20minutes.fr, 25 mars 2020
 Correspondance du Dr Vladimir Zelenko sur le traitement du COVID-19 à New York, hydroxychloroquine + azithromycin + zinc, in summary, my urgent recommendation is to begin outpatient treatment as soon as possible in accordance with the above. In my direct experience, this treatment prevents Acute Respiratory Distress Syndrome (ARDS), avoids the need for hospitalization and saves lives.
 Zinc as a Gatekeeper of Immune Function, Nutrients. 2017 Dec ; 9(12) : 1286.
 Zn (2+) inhibits coronavirus, PLoS Pathog. 2010 Nov 4;6(11):e1001176.
 Improving the efficacy of Chloroquine and Hydroxychloroquine against SARS-CoV-2 may require Zinc additives – A better synergy for future COVID-19 clinical trials, 1 juin 2020, free article
 Christian Perronne : “À Garches, nous avons de bons résultats avec l’hydroxychloroquine”, 15 avril 2020, A fervent advocate of hydroxychloroquine and azithromycin treatment, for Pr Christian Perronne the question of its effectiveness no longer arises. Head of the Infectious Diseases Department at the Raymond-Poincaré Hospital in Garches, he has seen it every day since the beginning of the epidemic: Professor Raoult’s treatment cures and considerably reduces the need for intensive care.
 Riposte à la covid-19 : la saine colère du Dr BELLATON, Source : page Facebook de Silviane Le Menn, 20 avril 2020.
 Coronavirus : le bilan très positif d’un praticien lorrain qui prescrit l’hydroxychloroquine, the Lorrain Republican, Philippe Marque, April 6, 2020. The results are more than positive: “I have used this protocol on a dozen hospitalized patients, who therefore have a Covid-19 that is already relatively worrying, and I have had neither death nor any evolution towards a serious stage requiring resuscitation.”
 Un médecin mosellan constate l’efficacité d’un protocole à base d’azithromycine, the Lorrain Republican, Thierry Fedrigo, April 11, 2020. Two Moselle doctors and one of their Belgian colleagues seem to have developed a drug combination effective against coronavirus. Relying on azithromycin without resorting to the hydroxychloroquine advocated by the infectiologist Didier Raoult, they have noted a clear drop in hospitalizations of their treated patients.
 Un médecin néerlandais soigne les patients atteints de coronavirus, mais le gouvernement néerlandais n’est pas content, Amari Roos, 10 avril 2020
 Des médecins algériens attestent de l’«efficacité quasi totale» de l’hydroxychloroquine contre le Covid-19, April 27, 2020. The heads of the infectious disease departments of a hospital in Blida and another in Algiers say that the hydroxychloroquine protocol followed in the treatment of patients with coronavirus gives a positive result “almost total”.
 Après l’Algérie, le Maroc encense l’efficacité de l’hydroxychloroquine contre le Covid-19, May 1, 2020. The therapeutic protocol based on hydroxychloroquine and azithromycin used against Covid-19 “has given positive results” in Morocco, the Health Minister said, adding that “side effects are minimal”.
 PROCÉDURE DE SÉCURISATION DE LA PRESCRIPTION DU TRAITEMENT HYDROXYCHLOROQUINE/AZITHROMYCINE, Service de cardiologie, Pr Deharo, Hôpital La Timone, AP-HM, Marseille, France, 1 avril 2020
 La corruption de la science. Le scandale de l’étude sur l’hydroxychloroquine. Qui était derrière tout cela ? L’intention d’Anthony Fauci de bloquer l’HCQ au nom des grandes entreprises pharmaceutiques, Michel Chossudovsky, mondialisation.ca, 12 juin 2020
 Treatment with Hydroxychloroquine Cut Death Rate Significantly in COVID-19 Patients
 «Nous sommes en train de dériver vers un totalitarisme qui ne dit pas son nom», 19 juillet 2020
 La vérité sur les compagnies pharmaceutiques, comment elles nous trompent, comment les contrecarrer, Marcia Angell, MD, ancienne rédactrice en chef du New England Journal of Medicine, traduction en français, les éditions le mieux-être, 2005.
 Un député et son collab’ chez Big Pharma, Cyril Pocréaux et François Ruffin, Fakir éditions, 2018
 Sanofi Big Pharma, l’urgence de la maîtrise sociale, Danielle Montel, Daniel Vergnaud, Danielle Sanchez, Thierry Bodin, Editions Syllepse, 2014
 Le grand secret de l’industrie pharmaceutique, Philippe Pignarre, La découverte/Poche 2004
 Les inventeurs de maladies, manœuvres et manipulations de l’industrie pharmaceutique, Jörg Blech, Actes Sud, 2005
 La Guerre des Médicaments, pourquoi sont-ils si chers ? Dirk Van Duppen, Aden éditions, collection epo, 2005
 La fabrique de malades, ces maladies qu’on nous invente, Dr Sauveur Boukris, le cherche midi éditions, 2013
 Impostures pharmaceutiques, médicaments illicites et luttes pour l’accès à la santé, Mathieu Quet, les empêcheurs de penser en rond / La découverte, 2018
 Big Pharma, une industrie toute-puissante qui joue avec notre santé, coordonné par Mikkel Borch-Jacobsen, Les Arènes, 2013
 Médicaments effets secondaires : la mort, les laboratoires nous trompent. John Virapen, le cherche midi éditions, 2014
 Santé-business ou la santé bafouée, Henri Van den Eynde, Editions EPO, 1995
 Corruptions et crédulité en médecine, Pr Philippe Even, Le cherche midi, 2015
 les médicamenteurs, labos, médecins, pouvoirs publics : enquête sur des liaisons dangereuses, Stéphane Horel, éditions du moment, 2010
 Lobbying à Paris, Bruxelles et Washington : l’énorme puissance de feu des labos, Olivier Petitjean, 13 novembre 2018.
 À Paris, l’influence écrasante des labos face aux associations de patients, Olivier Petitjean, 13 novembre 2018.
 Immersion dans un congrès de formation de médecins sponsorisé par Big Pharma, Rozenn Le Saint, 14 décembre 2018.
 Comment les labos se cachent derrière des campagnes de sensibilisation apparemment « neutres », Rozenn Le Saint, 30 novembre 2018.
 Médecine : la presse spécialisée sous la coupe de l’industrie pharmaceutique, Rozenn Le Saint, 30 novembre 2018
 Derrière les profits des labos, un soutien financier multiforme des pouvoirs publics, Olivier Petitjean, 16 janvier 2019.
 1000 milliards d’euros de profits en vingt ans : comment les labos sont devenus des monstres financiers, Olivier Petitjean, 16 janvier 2019.
 Coronavirus : GSK prochainement en mesure de réaliser au moins 6000 tests de dépistage par jour
 Coronavirus: les laboratoires de biologie clinique agréés, « écartés » au profit de firmes industrielles, n’ont plus confiance dans le gouvernement
 Et les conflits d’intérêts, on en parle ?, 5 mai 2020
The original source for this article Mondialisation.ca, 2020